Divergent epidemiology and antimicrobial resistance of bloodstream pathogens: a comparative study in a general tertiary care and a specialized cardiac institute
DOI:
https://doi.org/10.59736/IJP.23.04.1035Keywords:
Bloodstream infections, antimicrobial resistance, healthcare-associated infectionsAbstract
Background: Bloodstream infections (BSIs) are a critical cause of mortality globally, yet the profile of causative pathogens and their antimicrobial resistance (AMR) patterns vary dramatically across different healthcare settings. This study critically compared the BSI landscape between a specialized cardiac center (Peshawar Institute of Cardiology, PIC), which deals with high-risk nosocomial infections, and a general tertiary care hospital (Khyber Teaching Hospital, KTH), which handles a broad spectrum of community-acquired illnesses.
Methods: In total, 7,330 blood culture specimens (6,765 from KTH and 565 from PIC) were processed and rigorously identified. Antimicrobial Susceptibility Testing (AST) was performed using the VITEK 2 Compact Automated System and Kirby-Bauer disc diffusion, interpreted according to CLSI guidelines.
Results: The study revealed a bipartite epidemiology of BSIs. At Cardiac Center, the positivity rate was significantly higher (26.9%) and was overwhelmingly dominated by Gram-positive cocci (75%), characteristic of healthcare-associated infections. The principal pathogen was Staphylococcus aureus (48.7%). At General Hospital, the profile was a near-monomicrobial outbreak, with Gram-negative rods predominating (99%). The primary pathogen was Salmonella species (95.7%), reflecting a severe regional burden of community-acquired extensively drug-resistant enteric fever. All tested Gram-positive isolates retained 100% susceptibility to Linezolid, Vancomycin, and Teicoplanin. Similarly, Salmonella isolates showed 100% susceptibility to Carbapenems and Azithromycin. Salmonella exhibited near-universal resistance to Ciprofloxacin (0–2.2% susceptibility) and very poor susceptibility to Ceftriaxone.
Conclusion: This study provides a definitive, comparative profile of BSI pathogens in KP, demonstrating that the microbial threat is fundamentally linked to the healthcare environment. The reliance on last-line antibiotics is critical yet threatened by high resistance rates among common oral agents. Immediate clinical and policy action, informed by these institution-specific antibiograms, is urgently required to strengthen Antimicrobial Stewardship Programs and contain the spread of high-priority Multidrug-Resistant organisms.
References
Di Franco S, Alfieri A, Pace MC, Sansone P, Pota V, Fittipaldi C, et al. Blood Stream Infections from MDR Bacteria. Life. 2021 Jun 18;11(6):575.
Liu TP, Wu HF, Chang PL. Direct identification and antimicrobial susceptibility testing of microorganisms from positive blood culture bottles using a membrane filtration method. BMC Microbiol. 2025 Oct 2;25(1):606.
Chinemerem Nwobodo D, Ugwu MC, Oliseloke Anie C, Al‐Ouqaili MTS, Chinedu Ikem J, Victor Chigozie U, et al. Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace. J Clin Lab Anal. 2022 Sep 10;36(9).
Safdar N, Saleem S, Salman M, Tareq AH, Ishaq S, Ambreen S, et al. Economic burden of antimicrobial resistance on patients in Pakistan. Front Public Health. 2025 Feb 25;13.
Kalayci Cekin Z. Bloodstream Infections Caused by Multidrug Resistant Bacteria: Clinical and Microbiological Features and Mortality. SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital. 2023;416–25.
Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE, Aguilar GR, Mestrovic T, Smith G, Han C, Hsu RL. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. The Lancet. 2024 Sep 28;404(10459):1199-226
Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, Han C, Bisignano C, Rao P, Wool E, Johnson SC. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The lancet. 2022 Feb 12;399(10325):629-55.)
Ahmed SK, Hussein S, Qurbani K, Ibrahim RH, Fareeq A, Mahmood KA, et al. Antimicrobial resistance: Impacts, challenges, and future prospects. Journal of Medicine, Surgery, and Public Health. 2024 Apr;2:100081.
Oliveira M, Antunes W, Mota S, Madureira-Carvalho Á, Dinis-Oliveira RJ, Dias da Silva D. An Overview of the Recent Advances in Antimicrobial Resistance. Microorganisms. 2024 Sep 21;12(9):1920.
Bilal H, Khan MN, Rehman T, Hameed MF, Yang X. Antibiotic resistance in Pakistan: a systematic review of past decade. BMC Infect Dis. 2021 Dec 6;21(1):244.
Chitedze AC, Mzikamanda RR, Maida T, McAtee CL, Mapahla L, Feasey N, et al. Assessing the prevalence of antimicrobial resistance among pediatric patients at Kamuzu Central Hospital, Malawi. The Journal of Infection in Developing Countries. 2025 Aug 31;19(08):1172–81.
Paintsil EK, Adu-Asiamah CK, Kronsten VT, Ntuli Y, Shawcross DL. Global Trends in Antimicrobial Resistance Among Cirrhosis Patients with Bacteremia: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology. 2025 Jul 23.
Dadi NCT, Radochová B, Vargová J, Bujdáková H. Impact of Healthcare-Associated Infections Connected to Medical Devices—An Update. Microorganisms. 2021 Nov 11;9(11):2332.
Weiner-Lastinger LM, Abner S, Edwards JR, Kallen AJ, Karlsson M, Magill SS, et al. Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015–2017. Infect Control Hosp Epidemiol. 2020 Jan 26;41(1):1–18.
Allen KB, Fowler VG, Gammie JS, Hartzel JS, Onorato MT, DiNubile MJ, et al. Staphylococcus aureus Infections After Elective Cardiothoracic Surgery: Observations From an International Randomized Placebo-Controlled Trial of an Investigational S aureus Vaccine. Open Forum Infect Dis. 2014 Sep 1;1(2).
Tadros MA, Williams VR, Plourde S, Callery S, Simor AE, Vearncombe M. Risk factors for Staphylococcus aureus surgical site infection during an outbreak in patients undergoing cardiovascular surgery. American journal of infection control. 2013 Jun 1;41(6):509-12.
Carrier M, Marchand R, Auger P, Hébert Y, Pellerin M, Perrault LP, et al. Methicillin-resistant Staphylococcus aureus infection in a cardiac surgical unit. J Thorac Cardiovasc Surg. 2002 Jan;123(1):40–4.
Sousa-Uva* M, Head SJ, Milojevic M, Collet JP, Landoni G, Castella M, et al. 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery. European Journal of Cardio-Thoracic Surgery. 2018 Jan 1;53(1):5–33.
Ullah A, Shabil M, Abdulsamad SA, Jan A, Naeem AA, Ullah H, et al. Prevalence of the Antibiotic Resistance of Salmonella typhi and Salmonella paratyphi in Pakistan: A Systematic Review and Meta-analysis. Open Forum Infect Dis. 2025 Mar 27;12(4).
Akram J, Khan AS, Khan HA, Gilani SA, Akram SJ, Ahmad FJ, et al. Extensively Drug‐Resistant (XDR) Typhoid: Evolution, Prevention, and Its Management. Biomed Res Int. 2020 Jan 2;2020(1).
Zhu Q, Yue Y, Zhu L, Cui J, Zhu M, Chen L, et al. Epidemiology and microbiology of Gram-positive bloodstream infections in a tertiary-care hospital in Beijing, China: a 6-year retrospective study. Antimicrob Resist Infect Control. 2018 Sep 3;7(1):107.
Ullah A, Shabil M, Abdulsamad SA, Jan A, Naeem AA, Ullah H, Khattak M, Zakiullah. Prevalence of the Antibiotic Resistance of Salmonella typhi and Salmonella paratyphi in Pakistan: A Systematic Review and Meta-analysis. InOpen Forum Infectious Diseases 2025 Apr (Vol. 12, No. 4, p. ofaf131). US: Oxford University Press
Rapti V, Giannitsioti E, Spernovasilis N, Magiorakos AP, Poulakou G. The Evolving Landscape of Infective Endocarditis: Difficult-to-Treat Resistance Bacteria and Novel Diagnostics at the Foreground. J Clin Med. 2025 Mar 19;14(6):2087.
Chamat-Hedemand S, Dahl A, Østergaard L, Arpi M, Fosbøl E, Boel J, et al. Prevalence of Infective Endocarditis in Streptococcal Bloodstream Infections Is Dependent on Streptococcal Species. Circulation. 2020 Aug 25;142(8):720–30.
Hernández RB, Juliá MB. Enterococcus spp. and Streptococcus spp. bloodstream infections: epidemiology and therapeutic approach. Revista Española de Quimioterapia. 2023 Nov 27;36(Suppl 1):2.
Irfan Z, Afridi FI, Fatima A, Zafar H, Pervaiz YM, Farooq L. Prevalence of Extensively Drug Resistant Salmonella typhi and its susceptibility against meropenem, tigecycline, fosfomycin and azithromycin among clinical isolates from a tertiary care hospital laboratory: Susceptibility in Extensively Drug Resistant Salmonella typhi. Pakistan Journal of Health Sciences. 2024 Aug 31:49-54.
Khan M, Khattak MT, Gul A, Riaz M, Zahra FT. A comparable risk of extensively drug-resistant typhoid fever in the pediatric cohort during the COVID-19 pandemic. Int J Health Sci (Qassim). 2024;18(1):24–8.
Nizamuddin S, Ching C, Kamal R, Zaman MH, Sultan F. Continued Outbreak of Ceftriaxone-Resistant Salmonella enterica Serotype Typhi across Pakistan and Assessment of Knowledge and Practices among Healthcare Workers. Am J Trop Med Hyg. 2021 Jan 25;104(4):1265–70.
Ahmad J, Khan MA, Atif M, Rahman ZU, Nasir A, Ahmad HM, et al. Incidence and antimicrobial resistance profile of multi-drug resistant Salmonella typhi isolated from blood samples in Khyber Pakhtunkhwa, Pakistan. Diagn Microbiol Infect Dis. 2026 Feb;114(2):117122.
Lee YL, Wang WY, Ko WC, Hsueh PR. Global epidemiology and antimicrobial resistance of Enterobacterales harbouring genes encoding OXA-48-like carbapenemases: insights from the results of the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme 2018–2021. Journal of Antimicrobial Chemotherapy. 2024 Jul 1;79(7):1581–9.
Fadlallah M, Salem Sokhn E. Epidemiology and resistance profiles of Enterobacterales in a tertiary care hospital in Lebanon: a 4-year retrospective study. The Journal of Infection in Developing Countries. 2023 Jul 27;17(07):986–93.
Lee YL, Wang WY, Ko WC, Hsueh PR. Global epidemiology and antimicrobial resistance of Enterobacterales harbouring genes encoding OXA-48-like carbapenemases: insights from the results of the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme 2018–2021. Journal of Antimicrobial Chemotherapy. 2024 Jul;79(7):1581-9.
Epstein L, Mu Y, Belflower R, Scott J, Ray S, Dumyati G, et al. Risk Factors for Invasive Methicillin-Resistant Staphylococcus aureus Infection After Recent Discharge From an Acute-Care Hospitalization, 2011–2013. Clinical Infectious Diseases. 2016 Jan 1;62(1):45–52.
Farsi S, Salama I, Escalante-Alderete E, Cervantes J. Multidrug-Resistant Enterococcal Infection in Surgical Patients, What Surgeons Need to Know. Microorganisms. 2023 Jan 17;11(2):238.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Maria Khan, Amina Gul, Farooq Haider, Farman Ul Haq, Aakash Ahmad Khattak
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
